speb/financial-data huggingface dataset:
TXO balance_sheet (annual, 2023-12-31) — Invested Capital: 28100000.00
TXO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -46220000.00
TXO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 106277000.00
TXO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 86000000.00
TXO balance_sheet (annual, 2023-12-31) — Limited Partnership Capital: 473798000.00
TXO balance_sheet (annual, 2023-12-31) — Long Term Debt: 28100000.00
TXO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 28100000.00
TXO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 86000000.00
TXO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -178000000.00
TXO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 152222000.00
TXO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 106277000.00
TXO balance_sheet (annual, 2023-12-31) — Net Debt: 23595000.00
TXO income_statement (annual, 2023-12-31) — Net Income: -103987000.00
TXO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -103987000.00
TXO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -103987000.00
TXO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -103987000.00
TXO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -103987000.00
TXO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -103987000.00
TXO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -103987000.00
TXO income_statement (annual, 2023-12-31) — Net Interest Income: -3962000.00
TXO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -92000000.00
TXO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -92000000.00
TXO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -3962000.00
TXO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -144000.00
TXO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -35799000.00
TXO balance_sheet (annual, 2023-12-31) — Net PPE: 629323000.00
TXO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -10421000.00
TXO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 0.00
TXO balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 7131000.00
TXO income_statement (annual, 2023-12-31) — Normalized EBITDA: 168108000.00
TXO income_statement (annual, 2023-12-31) — Normalized Income: 119397000.00
TXO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 77150000.00
TXO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -23179000.00
TXO income_statement (annual, 2023-12-31) — Operating Income: 99603000.00
TXO income_statement (annual, 2023-12-31) — Operating Revenue: 380718000.00
TXO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 30750000.00
TXO balance_sheet (annual, 2023-12-31) — Other Current Assets: 12406000.00
TXO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 5406000.00
TXO income_statement (annual, 2023-12-31) — Other Gand A: 7887000.00
TXO income_statement (annual, 2023-12-31) — Other Income Expense: -199628000.00
TXO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -73469000.00
TXO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 3970000.00
TXO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 2377000.00
TXO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 23756000.00
TXO income_statement (annual, 2023-12-31) — Other Operating Expenses: 8795000.00
TXO balance_sheet (annual, 2023-12-31) — Other Properties: 1642438000.00
TXO income_statement (annual, 2023-12-31) — Other Taxes: 75415000.00
TXO balance_sheet (annual, 2023-12-31) — Payables: 13603000.00
TXO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 31960000.00
TXO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
TXO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
TXO income_statement (annual, 2023-12-31) — Pretax Income: -103987000.00
TXO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
TXO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -10421000.00
TXO balance_sheet (annual, 2023-12-31) — Receivables: 32226000.00
TXO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 189018000.00
TXO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 44288000.00
TXO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -178000000.00
TXO cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
TXO income_statement (annual, 2023-12-31) — Selling General And Administration: 7887000.00
TXO balance_sheet (annual, 2023-12-31) — Share Issued: 30750000.00
TXO income_statement (annual, 2023-12-31) — Special Income Charges: -223384000.00
TXO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3470000.00
TXO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 0.00
TXO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 0.00
TXO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
TXO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
TXO balance_sheet (annual, 2023-12-31) — Total Assets: 695613000.00
TXO balance_sheet (annual, 2023-12-31) — Total Capitalization: 501898000.00
TXO balance_sheet (annual, 2023-12-31) — Total Debt: 28100000.00
TXO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 473798000.00
TXO income_statement (annual, 2023-12-31) — Total Expenses: 281115000.00
TXO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 221815000.00
TXO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 640424000.00
TXO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 182699000.00
TXO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -123781000.00
TXO balance_sheet (annual, 2023-12-31) — Total Partnership Capital: 473798000.00
TXO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 5005000.00
TXO income_statement (annual, 2023-12-31) — Total Unusual Items: -223384000.00
TXO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -223384000.00
TXO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
TXO balance_sheet (annual, 2023-12-31) — Working Capital: 16073000.00
TXO income_statement (annual, 2023-12-31) — Write Off: 223384000.00
TXO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 39272000.00
TXO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.01
TXO balance_sheet (quarterly, 2024-09-30) — Capital Stock: 621379000.00
TXO balance_sheet (quarterly, 2024-09-30) — Common Stock: 621379000.00
TXO cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 18745000.00
TXO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 39828000.00
TXO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.01
TXO cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 18745000.00
TXO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 18745000.00
TXO income_statement (annual, 2024-12-31) — +Operating Expense: 86967000.00
TXO income_statement (annual, 2024-12-31) — +Total Revenue: 282810000.00
TXO balance_sheet (annual, 2024-12-31) — Accounts Payable: 18217000.00
TXO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 39689000.00
TXO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1065364000.00
TXO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
TXO income_statement (annual, 2024-12-31) — Basic Average Shares: 35559000.00
TXO income_statement (annual, 2024-12-31) — Basic EPS: 0.66
TXO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4505000.00
TXO cash_flow (annual, 2024-12-31) — Capital Expenditure: -265163000.00
TXO cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -3012000.00
TXO balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
TXO balance_sheet (quarterly, 2024-12-31) — Capital Stock: 0.00
TXO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 7305000.00
TXO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 7305000.00
TXO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -85355000.00
TXO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 181784000.00
TXO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -288283000.00
TXO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 109299000.00
TXO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1628000.00
TXO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 13277000.00
TXO cash_flow (annual, 2024-12-31) — Change In Receivables: -7991000.00
TXO cash_flow (annual, 2024-12-31) — Change In Working Capital: 6914000.00
TXO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -7991000.00
TXO cash_flow (annual, 2024-12-31) — Changes In Cash: 2800000.00
TXO balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
TXO balance_sheet (quarterly, 2024-12-31) — Common Stock: 0.00
TXO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -85355000.00
TXO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 0.00
TXO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 141233000.00
TXO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: -12000.00
TXO income_statement (annual, 2024-12-31) — Cost Of Revenue: 202704000.00
TXO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 28463000.00
TXO balance_sheet (annual, 2024-12-31) — Current Assets: 64447000.00
TXO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
TXO balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
TXO balance_sheet (annual, 2024-12-31) — Current Liabilities: 66337000.00
TXO balance_sheet (annual, 2024-12-31) — Current Provisions: 2000000.00
TXO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 52409000.00
TXO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 8022000.00
TXO income_statement (annual, 2024-12-31) — Diluted Average Shares: 36132000.00
TXO income_statement (annual, 2024-12-31) — Diluted EPS: 0.65
TXO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 23496000.00
TXO income_statement (annual, 2024-12-31) — EBIT: 31369000.00
TXO income_statement (annual, 2024-12-31) — EBITDA: 83778000.00
TXO cash_flow (annual, 2024-12-31) — End Cash Position: 7305000.00
TXO balance_sheet (annual, 2024-12-31) — Financial Assets: 2065000.00
TXO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 181784000.00
TXO cash_flow (annual, 2024-12-31) — Free Cash Flow: -155864000.00
TXO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 2566000.00
TXO income_statement (annual, 2024-12-31) — General And Administrative Expense: 14529000.00
TXO balance_sheet (annual, 2024-12-31) — Gross PPE: 2016755000.00
TXO income_statement (annual, 2024-12-31) — Gross Profit: 80106000.00
TXO balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 6412000.00
TXO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
TXO income_statement (annual, 2024-12-31) — Interest Expense: 7873000.00
TXO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 7873000.00
TXO income_statement (annual, 2024-12-31) — Interest Income: 1078000.00
TXO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1078000.00
TXO balance_sheet (annual, 2024-12-31) — Invested Capital: 157100000.00
TXO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -288283000.00
TXO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 141233000.00
TXO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -12000.00
TXO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 251000000.00
TXO balance_sheet (annual, 2024-12-31) — Limited Partnership Capital: 609416000.00
TXO balance_sheet (annual, 2024-12-31) — Long Term Debt: 157100000.00
TXO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 157100000.00
TXO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 251000000.00
TXO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -122000000.00
TXO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 188904000.00
TXO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 141233000.00
TXO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -12000.00
TXO balance_sheet (annual, 2024-12-31) — Net Debt: 149795000.00
TXO income_statement (annual, 2024-12-31) — Net Income: 23496000.00
TXO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 23496000.00
TXO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 23496000.00
TXO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 23496000.00
TXO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 23496000.00
TXO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 23496000.00
TXO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 23496000.00
TXO income_statement (annual, 2024-12-31) — Net Interest Income: -6795000.00
TXO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 129000000.00
TXO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 129000000.00
TXO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -6795000.00
TXO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -3094000.00
TXO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -23242000.00
TXO balance_sheet (annual, 2024-12-31) — Net PPE: 951391000.00
TXO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -265041000.00
TXO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 0.00
TXO balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 7131000.00
TXO income_statement (annual, 2024-12-31) — Normalized EBITDA: 83778000.00
TXO income_statement (annual, 2024-12-31) — Normalized Income: 23496000.00
TXO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 109299000.00
TXO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 2566000.00
TXO income_statement (annual, 2024-12-31) — Operating Income: -6861000.00
TXO income_statement (annual, 2024-12-31) — Operating Revenue: 282810000.00
TXO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 40913000.00
TXO balance_sheet (annual, 2024-12-31) — Other Current Assets: 11041000.00
TXO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 7193000.00
TXO income_statement (annual, 2024-12-31) — Other Gand A: 14529000.00
TXO income_statement (annual, 2024-12-31) — Other Income Expense: 37152000.00
TXO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 17749000.00
TXO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5807000.00
TXO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1062000.00
TXO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 37152000.00
TXO income_statement (annual, 2024-12-31) — Other Operating Expenses: 11996000.00
TXO balance_sheet (annual, 2024-12-31) — Other Properties: 2016755000.00
TXO income_statement (annual, 2024-12-31) — Other Taxes: 60442000.00
TXO balance_sheet (annual, 2024-12-31) — Payables: 23840000.00
TXO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 52303000.00
TXO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4841000.00
TXO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
TXO balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
TXO income_statement (annual, 2024-12-31) — Pretax Income: 23496000.00
TXO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
TXO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -265163000.00
TXO balance_sheet (annual, 2024-12-31) — Receivables: 39689000.00
TXO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 202704000.00
TXO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 52409000.00
TXO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -122000000.00
TXO cash_flow (annual, 2024-12-31) — Sale Of PPE: 122000.00
TXO income_statement (annual, 2024-12-31) — Selling General And Administration: 14529000.00
TXO balance_sheet (annual, 2024-12-31) — Share Issued: 40913000.00
TXO income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
TXO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 6165000.00
TXO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 0.00
TXO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 0.00
TXO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TXO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
TXO balance_sheet (annual, 2024-12-31) — Total Assets: 1030841000.00
TXO balance_sheet (annual, 2024-12-31) — Total Capitalization: 766516000.00
TXO balance_sheet (annual, 2024-12-31) — Total Debt: 157100000.00
TXO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 609416000.00
TXO income_statement (annual, 2024-12-31) — Total Expenses: 289671000.00
TXO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 421425000.00
TXO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 966394000.00
TXO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 355088000.00
TXO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -6861000.00
TXO balance_sheet (annual, 2024-12-31) — Total Partnership Capital: 609416000.00
TXO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 5623000.00
TXO income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
TXO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TXO balance_sheet (annual, 2024-12-31) — Working Capital: -1890000.00
TXO income_statement (annual, 2024-12-31) — Write Off: 0.00
TXO income_statement (quarterly, 2025-03-31) — +Operating Expense: 24208000.00
TXO income_statement (quarterly, 2025-03-31) — +Total Revenue: 84325000.00
TXO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 19782000.00
TXO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 38485000.00
TXO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1086727000.00
TXO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 41083000.00
TXO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.06
TXO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 7305000.00
TXO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -307000.00
TXO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 10842000.00
TXO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10842000.00
TXO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -25294000.00
TXO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -20230000.00
TXO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -6843000.00
TXO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 30610000.00
TXO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -1914000.00
TXO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -6309000.00
TXO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1195000.00
TXO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -7028000.00
TXO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1195000.00
TXO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 3537000.00
TXO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -25294000.00
TXO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 588733000.00
TXO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 63700000.00
TXO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 25915000.00
TXO balance_sheet (quarterly, 2025-03-31) — Current Assets: 81580000.00
TXO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 81952000.00
TXO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 3000000.00
TXO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 21429000.00
TXO balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 8489000.00
TXO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 41814000.00
TXO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.06
TXO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2416000.00
TXO income_statement (quarterly, 2025-03-31) — EBIT: 6037000.00
TXO income_statement (quarterly, 2025-03-31) — EBITDA: 27466000.00
TXO cash_flow (quarterly, 2025-03-31) — End Cash Position: 10842000.00
TXO balance_sheet (quarterly, 2025-03-31) — Financial Assets: 2289000.00
TXO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -20230000.00
TXO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 30303000.00
TXO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 9487000.00
TXO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2441000.00
TXO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2022392000.00
TXO income_statement (quarterly, 2025-03-31) — Gross Profit: 20625000.00
TXO balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 18849000.00
TXO income_statement (quarterly, 2025-03-31) — Interest Expense: 3621000.00
TXO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 3621000.00
TXO income_statement (quarterly, 2025-03-31) — Interest Income: 103000.00
TXO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 103000.00
TXO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 750833000.00
TXO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -6843000.00
TXO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 36000000.00
TXO balance_sheet (quarterly, 2025-03-31) — Limited Partnership Capital: 588733000.00
TXO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 162100000.00
TXO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 162100000.00
TXO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 36000000.00
TXO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -31000000.00
TXO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 190393000.00
TXO balance_sheet (quarterly, 2025-03-31) — Net Debt: 151258000.00
TXO income_statement (quarterly, 2025-03-31) — Net Income: 2416000.00
TXO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2416000.00
TXO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2416000.00
TXO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2416000.00
TXO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2416000.00
TXO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 2416000.00
TXO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2416000.00
TXO income_statement (quarterly, 2025-03-31) — Net Interest Income: -3518000.00
TXO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 5000000.00
TXO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 5000000.00
TXO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -3518000.00
TXO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 64000.00
TXO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -8291000.00
TXO balance_sheet (quarterly, 2025-03-31) — Net PPE: 935665000.00
TXO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 1448000.00
TXO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 0.00
TXO balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 7131000.00
TXO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 27466000.00
TXO income_statement (quarterly, 2025-03-31) — Normalized Income: 2416000.00
TXO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 30610000.00
TXO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 9487000.00
TXO income_statement (quarterly, 2025-03-31) — Operating Income: -3583000.00
TXO income_statement (quarterly, 2025-03-31) — Operating Revenue: 84325000.00
TXO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 41167000.00
TXO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 13404000.00
TXO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 27427000.00
TXO income_statement (quarterly, 2025-03-31) — Other Gand A: 2441000.00
TXO income_statement (quarterly, 2025-03-31) — Other Income Expense: 9517000.00
TXO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2175000.00
TXO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6640000.00
TXO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1638000.00
TXO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 9517000.00
TXO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3886000.00
TXO balance_sheet (quarterly, 2025-03-31) — Other Properties: 2022392000.00
TXO income_statement (quarterly, 2025-03-31) — Other Taxes: 17881000.00
TXO balance_sheet (quarterly, 2025-03-31) — Payables: 24281000.00
TXO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 50196000.00
TXO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1329000.00
TXO income_statement (quarterly, 2025-03-31) — Pretax Income: 2416000.00
TXO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -307000.00
TXO balance_sheet (quarterly, 2025-03-31) — Receivables: 38485000.00
TXO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 63700000.00
TXO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 21429000.00
TXO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -31000000.00
TXO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 1755000.00
TXO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2441000.00
TXO balance_sheet (quarterly, 2025-03-31) — Share Issued: 41167000.00
TXO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2131000.00
TXO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 0.00
TXO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 588733000.00
TXO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TXO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
TXO balance_sheet (quarterly, 2025-03-31) — Total Assets: 1033305000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 750833000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Debt: 162100000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 588733000.00
TXO income_statement (quarterly, 2025-03-31) — Total Expenses: 87908000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 444572000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 951725000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 362620000.00
TXO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3583000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Partnership Capital: 588733000.00
TXO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 4499000.00
TXO balance_sheet (quarterly, 2025-03-31) — Working Capital: -372000.00
TXO income_statement (quarterly, 2025-06-30) — +Operating Expense: 28576000.00
TXO income_statement (quarterly, 2025-06-30) — +Total Revenue: 89879000.00
TXO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 18779000.00
TXO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 36991000.00
TXO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1108411000.00
TXO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 48220000.00
TXO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
TXO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 10842000.00
TXO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -34303000.00
TXO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 7953000.00
TXO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 7953000.00
TXO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -32312000.00
TXO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 12980000.00
TXO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -42723000.00
TXO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 26854000.00
TXO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -237000.00
TXO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1041000.00
TXO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 2701000.00
TXO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1423000.00
TXO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 2701000.00
TXO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2889000.00
TXO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -32312000.00
TXO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 753024000.00
TXO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 65018000.00
TXO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 26568000.00
TXO balance_sheet (quarterly, 2025-06-30) — Current Assets: 70756000.00
TXO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 72713000.00
TXO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 3000000.00
TXO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 21684000.00
TXO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 7184000.00
TXO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 48220000.00
TXO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
TXO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -135000.00
TXO income_statement (quarterly, 2025-06-30) — EBIT: 2436000.00
TXO income_statement (quarterly, 2025-06-30) — EBITDA: 24120000.00
TXO cash_flow (quarterly, 2025-06-30) — End Cash Position: 7953000.00
TXO balance_sheet (quarterly, 2025-06-30) — Financial Assets: 4982000.00
TXO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 12980000.00
TXO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -7449000.00
TXO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -14835000.00
TXO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 9454000.00
TXO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2066767000.00
TXO income_statement (quarterly, 2025-06-30) — Gross Profit: 24861000.00
TXO balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 12171000.00
TXO income_statement (quarterly, 2025-06-30) — Interest Expense: 2571000.00
TXO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2571000.00
TXO income_statement (quarterly, 2025-06-30) — Interest Income: 300000.00
TXO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 300000.00
TXO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 772124000.00
TXO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -42723000.00
TXO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 52500000.00
TXO balance_sheet (quarterly, 2025-06-30) — Limited Partnership Capital: 753024000.00
TXO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 19100000.00
TXO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 19100000.00
TXO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 52500000.00
TXO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -195500000.00
TXO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 193553000.00
TXO balance_sheet (quarterly, 2025-06-30) — Net Debt: 11147000.00
TXO income_statement (quarterly, 2025-06-30) — Net Income: -135000.00
TXO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -135000.00
TXO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -135000.00
TXO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -135000.00
TXO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -135000.00
TXO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -135000.00
TXO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -135000.00
TXO income_statement (quarterly, 2025-06-30) — Net Interest Income: -2271000.00
TXO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -143000000.00
TXO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -143000000.00
TXO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2271000.00
TXO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1210000.00
TXO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -6665000.00
TXO balance_sheet (quarterly, 2025-06-30) — Net PPE: 958356000.00
TXO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -36058000.00
TXO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 0.00
TXO balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 7131000.00
TXO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 24120000.00
TXO income_statement (quarterly, 2025-06-30) — Normalized Income: -135000.00
TXO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 26854000.00
TXO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -14835000.00
TXO income_statement (quarterly, 2025-06-30) — Operating Income: -3715000.00
TXO income_statement (quarterly, 2025-06-30) — Operating Revenue: 89879000.00
TXO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 54784292.00
TXO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 13641000.00
TXO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 17313000.00
TXO income_statement (quarterly, 2025-06-30) — Other Gand A: 9454000.00
TXO income_statement (quarterly, 2025-06-30) — Other Income Expense: 5851000.00
TXO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 11481000.00
TXO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5455000.00
TXO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1106000.00
TXO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 5851000.00
TXO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3888000.00
TXO balance_sheet (quarterly, 2025-06-30) — Other Properties: 2066767000.00
TXO income_statement (quarterly, 2025-06-30) — Other Taxes: 15234000.00
TXO balance_sheet (quarterly, 2025-06-30) — Payables: 23027000.00
TXO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 49595000.00
TXO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 2805000.00
TXO income_statement (quarterly, 2025-06-30) — Pretax Income: -135000.00
TXO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -34303000.00
TXO balance_sheet (quarterly, 2025-06-30) — Receivables: 36991000.00
TXO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 65018000.00
TXO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 21684000.00
TXO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -195500000.00
TXO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: -1755000.00
TXO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 9454000.00
TXO balance_sheet (quarterly, 2025-06-30) — Share Issued: 54784292.00
TXO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7236000.00
TXO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 0.00
TXO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 753024000.00
TXO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TXO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Assets: 1046680000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 772124000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Debt: 19100000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 753024000.00
TXO income_statement (quarterly, 2025-06-30) — Total Expenses: 93594000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 293656000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 975924000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 220943000.00
TXO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3715000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Partnership Capital: 753024000.00
TXO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 4248000.00
TXO balance_sheet (quarterly, 2025-06-30) — Working Capital: -1957000.00
TXO income_statement (quarterly, 2025-09-30) — +Operating Expense: 25555000.00
TXO income_statement (quarterly, 2025-09-30) — +Total Revenue: 100876000.00
TXO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 29664000.00
TXO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 45602000.00
TXO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1132108000.00
TXO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 54784000.00
TXO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.08
TXO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 7953000.00
TXO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -234804000.00
TXO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5308000.00
TXO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5308000.00
TXO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -24624000.00
TXO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 224950000.00
TXO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -255866000.00
TXO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 28271000.00
TXO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 425000.00
TXO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 7812000.00
TXO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -8571000.00
TXO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -334000.00
TXO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -8571000.00
TXO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2645000.00
TXO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -24624000.00
TXO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 736220000.00
TXO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
TXO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 71561000.00
TXO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 36882000.00
TXO balance_sheet (quarterly, 2025-09-30) — Current Assets: 76921000.00
TXO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 70000000.00
TXO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 160617000.00
TXO balance_sheet (quarterly, 2025-09-30) — Current Provisions: 3500000.00
TXO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 23697000.00
TXO balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 2115000.00
TXO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 55807000.00
TXO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.08
TXO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 4352000.00
TXO income_statement (quarterly, 2025-09-30) — EBIT: 8857000.00
TXO income_statement (quarterly, 2025-09-30) — EBITDA: 32554000.00
TXO cash_flow (quarterly, 2025-09-30) — End Cash Position: 5308000.00
TXO balance_sheet (quarterly, 2025-09-30) — Financial Assets: 1203000.00
TXO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 224950000.00
TXO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -206533000.00
TXO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -10320000.00
TXO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4834000.00
TXO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2416637000.00
TXO income_statement (quarterly, 2025-09-30) — Gross Profit: 29315000.00
TXO balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 11095000.00
TXO income_statement (quarterly, 2025-09-30) — Interest Expense: 4505000.00
TXO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 4505000.00
TXO income_statement (quarterly, 2025-09-30) — Interest Income: 113000.00
TXO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 113000.00
TXO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1007320000.00
TXO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -255866000.00
TXO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
TXO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 272000000.00
TXO balance_sheet (quarterly, 2025-09-30) — Limited Partnership Capital: 736220000.00
TXO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 271100000.00
TXO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 271100000.00
TXO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 272000000.00
TXO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -20000000.00
TXO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 205426000.00
TXO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
TXO balance_sheet (quarterly, 2025-09-30) — Net Debt: 265792000.00
TXO income_statement (quarterly, 2025-09-30) — Net Income: 4352000.00
TXO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 4352000.00
TXO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 4352000.00
TXO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 4352000.00
TXO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 4352000.00
TXO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 4352000.00
TXO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 4352000.00
TXO income_statement (quarterly, 2025-09-30) — Net Interest Income: -4392000.00
TXO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 252000000.00
TXO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 252000000.00
TXO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4392000.00
TXO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2426000.00
TXO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -21062000.00
TXO balance_sheet (quarterly, 2025-09-30) — Net PPE: 1284529000.00
TXO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -234804000.00
TXO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 0.00
TXO balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 7131000.00
TXO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 32554000.00
TXO income_statement (quarterly, 2025-09-30) — Normalized Income: 4352000.00
TXO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 28271000.00
TXO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -10320000.00
TXO income_statement (quarterly, 2025-09-30) — Operating Income: 3760000.00
TXO income_statement (quarterly, 2025-09-30) — Operating Revenue: 100876000.00
TXO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 54784292.00
TXO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 14916000.00
TXO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 10276000.00
TXO income_statement (quarterly, 2025-09-30) — Other Gand A: 4834000.00
TXO income_statement (quarterly, 2025-09-30) — Other Income Expense: 4984000.00
TXO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 7408000.00
TXO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 6374000.00
TXO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 680000.00
TXO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 4984000.00
TXO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 4073000.00
TXO balance_sheet (quarterly, 2025-09-30) — Other Properties: 2416637000.00
TXO income_statement (quarterly, 2025-09-30) — Other Taxes: 16648000.00
TXO balance_sheet (quarterly, 2025-09-30) — Payables: 35469000.00
TXO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 72351000.00
TXO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 4490000.00
TXO income_statement (quarterly, 2025-09-30) — Pretax Income: 4352000.00
TXO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -234804000.00
TXO balance_sheet (quarterly, 2025-09-30) — Receivables: 45602000.00
TXO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 71561000.00
TXO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 23697000.00
TXO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -20000000.00
TXO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
TXO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4834000.00
TXO balance_sheet (quarterly, 2025-09-30) — Share Issued: 54784292.00
TXO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3468000.00
TXO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 0.00
TXO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 736220000.00
TXO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TXO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
TXO balance_sheet (quarterly, 2025-09-30) — Total Assets: 1376158000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1007320000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Debt: 271100000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 736220000.00
TXO income_statement (quarterly, 2025-09-30) — Total Expenses: 97116000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 639938000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1299237000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 479321000.00
TXO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 3760000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Partnership Capital: 736220000.00
TXO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 5805000.00
TXO balance_sheet (quarterly, 2025-09-30) — Working Capital: -83696000.00
TXO income_statement (annual, 2025-12-31) — +Operating Expense: 106365000.00
TXO income_statement (quarterly, 2025-12-31) — +Operating Expense: 28026000.00
TXO income_statement (annual, 2025-12-31) — +Total Revenue: 401012000.00
TXO income_statement (quarterly, 2025-12-31) — +Total Revenue: 125932000.00
TXO balance_sheet (annual, 2025-12-31) — Accounts Payable: 27979000.00
TXO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 27979000.00
TXO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 52391000.00
TXO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 52391000.00
TXO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1204261000.00
TXO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1204261000.00
TXO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 42425000.00
TXO income_statement (annual, 2025-12-31) — Basic Average Shares: 49769000.00